Insider Trading History of Kent Richard S

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Kent Richard S since 2013. The trader's CIK number is 1292660. At the time of the last reporting, Kent Richard S was the Director of Melinta Therapeutics, Inc. /new/. (stock ticker symbol MLNT). Also see all insider trading activities at Melinta Therapeutics, Inc. /new/.

Note that in the past Kent Richard S also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Melinta Therapeutics, Inc. /new/ (CEMP) by Kent Richard S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 CEMP 0 $0 0 $0 15,000 $196,500

Yearly summary of insider trading at Cytomedix Inc (CMXI) by Kent Richard S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 CMXI 963,637 $530,000 0 $0 0 $0


Insider trading activities at 2 companies by Kent Richard S:

1. Melinta Therapeutics, Inc. /new/ (CEMP)

2. Cytomedix Inc (CMXI)

Table 1. Insider trading of Melinta Therapeutics, Inc. /new/ (CEMP) by Kent Richard S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-03-04 CEMP Option Ex 15,000 13.10 196,500

Table 2. Insider trading of Cytomedix Inc (CMXI) by Kent Richard S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-02-22 CMXI Buy 963,637 .55 530,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kent Richard S (Director of Melinta Therapeutics, Inc. /new/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.